team
Valentina Marulanda Corzo is a Clinical Research Fellow in Molecular Imaging and Therapeutics at Weill Cornell Medicine. She received her medical degree from Pontificia Universidad Javeriana in Colombia, and has an outstanding academic background, including research experience in urology and general surgery.
Prior to joining the team at Weill Cornell, Valentina collaborated with multidisciplinary teams to streamline processes and deliver better patient outcomes. At the Anticoagulation Clinic at Hospital Universitario San Ignacio where she conducted patient consultations and led critical data collection and audits improving operational efficiency. Valentina also gained valuable experience through clinical rotations in internal medicine and pediatric anesthesiology at the University of Florida Shands Hospital in Gainesville.
Valentina is deeply committed to advancing healthcare in underserved communities. She has volunteered with organizations focused on expanding access to healthcare and education, and she has mentored students in leadership development. These experiences reflect her passion for impactful, community-centered healthcare initiatives.
With a focus on enhancing patient care through research and innovation, Valentina aspires to further her career in diagnostic radiology. Fluent in both Spanish and English, Valentina brings a global perspective to the team.
Joseph R. Osborne, M.D., Ph.D. is a distinguished expert in molecular imaging and radiology, currently serving as Chief of the Molecular Imaging & Therapeutics Service and Professor of Radiology at Weill Cornell Medical College. With an educational foundation that includes a Ph.D. in Cellular and Molecular Biophysics and an M.D. from Columbia University, Osborne has cultivated a profound impact on cancer imaging and therapy.
His research career began under the mentorship of Nobel Laureate Richard Axel, where he developed a strong focus on molecular imaging probes and theranostics, specifically prostate-specific membrane antigen (PSMA) imaging, used in the diagnosis and treatment of prostate cancer.
Dr. Osborne has held various key leadership roles, including his time at Memorial Sloan Kettering Cancer Center as Associate Vice Chairman of Research in Radiology and the Director of Molecular Imaging and Therapy Residency/Fellowship programs. His leadership extends to promoting health equity in radiology, exemplified by his role as Director of the Rad Health Equity Laboratory, where his research addresses both the development of cost-effective diagnostics and addressing healthcare disparities in imaging.
Dr. Osborne’s extensive publication record includes over 80 peer-reviewed papers, contributing significantly to advances in prostate cancer imaging, personalized medicine, and the role of genomic markers in radiological practices. He has led groundbreaking clinical trials focused on novel theranostic approaches to cancer treatment and imaging, which have opened new pathways for integrating diagnostics and therapy in oncology.
His research initiatives have received substantial funding from prominent institutions, including the National Institutes of Health (NIH) and the Department of Defense, further cementing his position as a leading figure in nuclear medicine and molecular imaging.
In addition to his academic and research accomplishments, Osborne has been actively involved in national committees such as the American Thyroid Association’s task force and the FDA’s Medical Imaging Drugs Advisory Committee, contributing to policy shaping and the advancement of diagnostic radiopharmaceuticals.
Dr. Osborne’s career reflects a commitment to innovation, interdisciplinary collaboration, and the pursuit of equity in healthcare, particularly in access to advanced imaging technologies .
Recommended
- A Conversation Between Joseph Osborne and Thomas Hope
- Racial/Ethnic Disparities in Genomic Sequencing
- Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate cancer men
- Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality
- Access to cardiac PET/CT by sarcoidosis patients and cost-effectiveness analysis of cardiac PET/MR compared to the standard of care
- Social and Demographic Influences of Trust in Cancer Information Among Brooklyn, New York Residents
- Cancer Health Impact Program (CHIP): Identifying Social and Demographic Associations of mHealth Access and Cancer Screening Behaviors Among Brooklyn, New York, Residents
- Disparities in Castration-Resistant Prostate Cancer Trials
- Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial
Dr. T. Kemi Babagbemi is a board certified radiologist specializing in Women’s Imaging. Dr. Babagbemi has been full time faculty at Weill Cornell Medicine since 2006. She is currently an Associate Professor of Clinical Radiology at Weill Cornell Medicine and Associate Attending Radiologist at New York-Presbyterian Hospital-Weill Cornell Campus. Dr. Babagbemi is also the inaugural Vice Chair for Diversity, Equity, and Inclusion in the Department of Radiology.
Dr. Babagbemi earned her B.S. degree, Summa Cum Laude, from Georgia State University, Atlanta, GA in 1994 and was awarded her M.D. degree from Harvard Medical School, Boston, MA in 1998. Dr. Babagbemi was an intern (1998-1999) at The Cambridge Hospital/Harvard Medical School, Cambridge, MA. She then completed her residency training (1999-2003) in Diagnostic Radiology at the Brigham and Women’s Hospital in Boston, MA. Dr. Babagbemi was elected Chief Radiology Resident in 2001-2002. She remained at the Brigham and Women’s Hospital for additional training in Women’s Imaging and Emergency Radiology. Prior to joining Weill Cornell, Dr. Babagbemi was an attending radiologist at the Brigham and Women’s Hospital and the Dana-Farber Cancer Institute in both the Ultrasound and Breast Imaging departments.
Dr. Babagbemi’s clinical expertise is in Women’s imaging (mammography, breast ultrasound, breast MRI and image guided procedures) and ultrasonography (including early obstetrical and gynecological ultrasound).
Dr. Babagbemi is very active and involved in the teaching of radiology residents and medical students. She is the creator and course director for the Diversity Visiting Student Internship in Radiology designed to help increase exposure for those students historically underrepresented in Medicine, and specifically Radiology. She is the 2022 recipient of the prestigious Jeanne and Herbert Siegel award for Excellence in Medical Education at Weill Cornell Medicine.
Currently, Dr. Babagbemi serves as the team captain for the national radiology team #RadsforFood as part of the X( Twitter) based annual Healthcare Workers vs Hunger fundraising competition to raise money for food banks nationwide. The team raised $234,351 and won the 2023 national competition.
Recommended
- CDC’s National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides breast and cervical cancer screenings and diagnostic services to women who have low incomes and are uninsured or underinsured. Find A Screening Program Near You
- ACR/SBI Comment on Draft USPSTF Breast Cancer Screening Recommendations
Manny Paris is a highly accomplished healthcare executive with over 25 years of experience in radiology and healthcare administration. He currently serves as the Director of Radiology Healthcare Administration at the University of Florida College of Medicine in Jacksonville. His extensive expertise includes health equity, molecular imaging, theranostics, strategic planning, program development, and operations management.
Manny’s career is marked by his leadership in radiology services in several prestigious healthcare institutions. At Memorial Sloan Kettering, he managed one of the nation’s leading Molecular Imaging and Therapeutics Services. There, he collaborated with global experts to spearhead innovations in nuclear medicine, PET/CT, and theranostics. He later served as the Director of Diagnostic Imaging and Interventional Radiology at New York Presbyterian-HVH, where he played a pivotal role in enhancing the institution’s cancer care services, acting as interim Director of the Cancer Center on two occasions, and as an Administrator on-call during the Covid period.
In addition to his work in healthcare management, Manny co-founded Rad Health Equity, a consulting firm dedicated to improving access to high-quality diagnostic and interventional services in underserved communities. His work in this field is recognized through his involvement in groundbreaking research on health disparities and access to cancer care.
Manny holds a Master’s degree in History from Rutgers University, a B.S. in Biology, a B.A. in History from William Paterson University, and a Nuclear Medicine Technology degree from the University of Medicine & Dentistry of New Jersey. Throughout his career, Manny has been a leader in expanding access to advanced diagnostic imaging technologies, continuously advocating for equitable care.
His contributions to healthcare research are notable, with published papers addressing disparities in access to cancer care, patient satisfaction across diverse cultural and linguistic backgrounds, and innovative approaches to integrating molecular imaging into oncology services.
Manny Paris’ career reflects a deep commitment to improving healthcare services and outcomes for all patients, particularly those in underserved communities. His passion for innovation and strategic leadership continues to drive meaningful change in the healthcare sector.
Recommended
- Eliminate Inequities – National Cancer Plan
- RSNA Editorial: Imaging Cancer. Alternate CMS Payment Structure for Outpatient Services: A Road to Improving Access to Molecular Imaging in Oncologic Care
- Cancer Epidemiology, Biomarkers & Prevention. Cancer Health Impact Program (CHIP): Identifying Social and Demographic Associations of mHealth Access and Cancer Screening Behaviors Among Brooklyn, New York, Residents
- Racial Disparities in Lung Cancer Screening Among Veterans, 2013 to 2021
- The Patient Experience of Prior Authorization for Cancer Care
Dr. Lauren Groner, D.O., M.S., is an Assistant Professor of Clinical Radiology at Weill Cornell Medicine and an Assistant Attending Radiologist at NewYork-Presbyterian/Weill Cornell Medicine, with a specialty in Cardiothoracic Imaging.
Dr. Groner earned her B.S. in Physiology from Michigan State University in 2007 and her D.O. from Michigan State University College of Osteopathic Medicine in 2013. She completed a one-year internship at Maimonides Medical Center, followed by a residency in Diagnostic Radiology at Atlantic Health System/Sidney Kimmel Medical College at Thomas Jefferson University, finishing in 2018. She then pursued a fellowship in Cardiothoracic Imaging at Weill Cornell Medicine, completed in 2019. In May 2023, Dr. Groner earned an M.S. in Clinical Epidemiology and Health Services Research from Weill Cornell Medical College.
As an early-stage investigator, Dr. Groner’s research addresses social determinants of health that contribute to cardiopulmonary health disparities, with a focus on lung cancer and cardiovascular disease. She is the principal investigator of the IBREATHE study, funded by the Dalio Center for Health Justice, which utilizes implementation science to pilot a multicomponent behavior change intervention aimed at overcoming barriers to equitable, guideline-concordant lung cancer screening in primary care settings.
Dr. Groner is an active member of the Meyer Cancer Center’s Cancer Prevention and Control Group and recently joined the Board of Directors of Physicians for a National Health Program—NY Metro Chapter. Additionally, she participates in the CDC Lung Cancer Working Group and the NYS Cancer Consortium’s Lung Cancer Screening Action Team (LCSAT), where she serves on the Legislative and Education subcommittees.
Recommended
Olive C. Osborne, M.D. is a board-certified ophthalmologist with over 25 years of experience in private practice. She has served as an attending physician at the New York Eye and Ear Infirmary, Mount Sinai Medical Center, and Montefiore Medical Center.
Dr. Osborne earned her M.D. from Brown University School of Medicine, followed by an internal medicine internship at Westchester Medical Center. She completed her ophthalmology residency at SUNY Downstate Health Science University and went on to pursue a surgical and medical vitreoretinal fellowship at Southern Illinois University.
As the Community Engagement Manager for Rad Health Equity, Dr. Osborne excels in navigating complex regulatory landscapes, fostering interdisciplinary collaboration, and leveraging technology to drive innovation. Her track record includes enhancing operational efficiency, improving patient care, and driving revenue growth within complex healthcare systems. Dr. Osborne’s expertise lies in strategic planning, team leadership, and resource allocation, all aimed at achieving excellence in patient outcomes and organizational performance.
Dr. Kritika Subramanian, MD, MS is a distinguished physician-scientist and Radiation Oncology resident at Montefiore Hospital. Her multifaceted career is marked by a unique blend of clinical excellence, academic achievements, and groundbreaking research contributions in molecular imaging, oncologic care, and global health.
Education and Training
• PhD Candidate (Microbiology and Immunology): Rega Institute of Medical Research, KU Leuven
• Master of Science in Clinical Investigation: Weill Cornell Medicine
• Residencies: Molecular Imaging and Therapeutics (New York-Presbyterian Hospital); Radiation Oncology (Montefiore Hospital, Bronx, NY)
• Doctor of Medicine: St. George’s University School of Medicine
• Bachelor of Science (Biology, Global Health): Emory University
Key Accomplishments
• Research Leadership: As Chief Resident (2021–2023), she led projects on cost-effectiveness and access disparities in oncologic imaging and therapy, earning numerous awards.
• Publications: Authored over 20 peer-reviewed articles in prestigious journals, including JCO Precision Oncology and Radiology: Imaging Cancer. Her work spans innovative imaging techniques, racial and socioeconomic healthcare equity, and precision oncology.
• Awards: First place in the NYACP Spring 2021 Resident and Fellow Research Competition; St. George’s University Senior Medical Student Research Award.
• Innovations in Imaging: Contributed to developing novel radiopharmaceuticals and pioneering cost-effective, equitable imaging strategies for underserved populations.
Extracurricular and Consulting
Dr. Subramanian’s global perspective is enriched by her role as a consultant for Sphur LLC and research internships at renowned institutions like the Winship Cancer Institute. She actively participates in international medical organizations to address global health disparities.
Professional Affiliations
• Society of Nuclear Medicine and Molecular Imaging
• International Lymphoma Epidemiology Consortium
• American Society of Clinical Oncology
Dr. Subramanian’s expertise in global health, cancer biology, and innovative imaging technologies cements her reputation as a leader dedicated to advancing equitable cancer care worldwide.
Recommended
Kyla Nixon is a radiopharmaceutical research technician with the division of Molecular Imaging and Therapeutics at Weill Cornell Medicine. While completing her undergraduate studies focusing on biological sciences and journalism, Kyla gained experience using social media to recruit African American men for prostate cancer research. As part of the Rad Health Equity team, Kyla aims to address the communication gap in radiology and medicine through her writing skills. Using her background and interest in medical journalism and the RHE online platform, she hopes to amplify patient voices and bring patient advocates into the clinical trials space.
Recommended
- NPR: Black Americans expect to face racism in the doctor’s office, survey finds.
- Time: The History Behind America’s Devastating Shortage of Black Doctors
Dr. Andres Ricaurte-Fajardo has been a part of our team since 2022. He completed his M.D. at Pontificia Universidad Javeriana in Bogota, Colombia, followed by a postdoctoral fellowship in molecular imaging and therapeutics at Weill Cornell Medicine in New York City. He is currently in his residency in clinical neurology.
Dr. Ricaurte Fajardo’s research interests include stroke, reversible cerebral vasoconstriction syndrome, neurodegenerative diseases, cancer imaging, and health equity. He is also a strong advocate for high-quality medical education. During his time at Weill Cornell, he served as a problem-based learning facilitator for the Essential Principles of Medicine (EPOM) course, where he instructed first-year medical students in fundamental concepts encompassing science, patient care, and physicianship. He fostered an interactive learning environment that encouraged active participation and collaborative problem-solving among students.
He has authored numerous papers on these topics in world-class journals and has presented at some of the most prestigious neurology, radiology, and oncology conferences worldwide. His strong leadership skills are demonstrated through his coordination and improvement of radiotherapeutic care for cancer patients in clinical trials, as well as his involvement in the Weill Cornell Meyer Cancer Center as a member of the Trainee Advisory Council.
In recognition of his impactful contributions to underserved communities, Dr. Ricaurte Fajardo has received more than six honors in recent years, including the 2023 Pioneer in Diversity Louis Wade Sullivan, M.D. Award at Weill Cornell Medicine. Additionally, he received the Ralph Blumhardt Award from the American College of Nuclear Medicine and the Hill Day Travel Award from Weill Cornell Medicine, the American Association of Cancer Research, and the Association of American Cancer Institutes. This prestigious opportunity enabled him to advocate for increased funding for cancer research to the National Cancer Institute in the U.S. Capitol, engaging with congressional teams alongside a select group of cancer experts from leading institutions in the United States.
Currently, he is focused on theranostics, neurodegenerative diseases, and vascular neurology research aimed at reducing healthcare disparities, utilizing his international experience and global perspective to tackle health issues both locally and globally.
Recommended
Dr. Sandra Huicochea Castellanos is a radiologist and board-certified nuclear medicine physician specializing in Oncologic Imaging. She is Assistant Professor of Clinical Radiology at Weill Cornell Medicine and an Assistant Attending Radiologist at New York Presbyterian Hospital/Weill Cornell Campus.
Dr. Huicochea Castellanos completed her residency training in Diagnostic Radiology in Mexico City. After working for five years as a radiologist in Mexico she moved to New York and completed a residency in Nuclear Medicine at Memorial Sloan Kettering Cancer Center. As a Latina, she has a better understanding of some of the social factors that impact the health among the Hispanic population. Also, as a native Spanish speaker, she is able to overcome the language barrier that many in this demographic population face. Dr. Huicochea Castellanos focuses her research efforts on clinical and radiological research focused around prostate cancer. As part of Rad Health Equity, she hopes to increase the awareness surrounding cancer-related healthcare disparities as a means of addressing health equity.